Cytochrome P450 modification by a new oxazine derivative with hypolipidemic activity

Research Communications in Molecular Pathology and Pharmacology

Volumn 108, Issue 5-6, 2000, Pages 325-331

  Chrysselis, Michael C ^a   Rekka, Eleni A ^a   Kourounakis, Panos N ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4 BIPHENYL) 3 N PROPOXYOCTAHYDRO 1,4 PYRIDO[2,1 C]OXAZINE; 4 NITROPHENOL HYDROXYLASE; ANTILIPEMIC AGENT; CYTOCHROME P450; CYTOCHROME P450 3A; LIVER PROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OXAZINE DERIVATIVE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG METABOLISM; ENZYME ACTIVITY; LIVER MICROSOME; LIVER WEIGHT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTICHOLESTEREMIC AGENTS; ANTILIPEMIC AGENTS; CHOLESTEROL; CHOLESTEROL, LDL; CYTOCHROME P-450 ENZYME SYSTEM; HYPERLIPIDEMIAS; ISOENZYMES; LIPID PEROXIDATION; LIPOPROTEINS; MALE; MICROSOMES, LIVER; ORGAN SIZE; OXAZINES; RATS; RATS, INBRED F344; SPECTROPHOTOMETRY, ULTRAVIOLET; TRIGLYCERIDES;

EID: 0034582845     PISSN: 10780297     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Influence of mercury and cadmium intoxication on hepatic microsomal CYP2E and CYP3A subfamilies
2. A receptror-mediated pathway for cholesterol homeostasis
3. Hypocholesterolemic and hypolipidemic activity of some novel morpholine derivatives
4. Structural basis of selective cytochrome P450 inhibition
5. To drink or not to drink?
6. Protein measurement with the Folin phenol reagent
7. Microsmal enzyme induction, lipoproteins and atherosclerosis
8. Relationship between plasma HDL cholesterol and anticonvulsant levels in epileptics
9. Increase in apolipoprotein A-I/A-II ratio in phenytoin users - Positive relation to liver protein and cytochrome P-450
10. The CYP3A family
11. Effect of enzyme induction on plasma lipids using antipyrine, phenobarbital and rifampicin
12. The carbon monoxide pigment of liver microsomes I. Evidence for its haemoprotein nature
13. Suicidal destruction of cytochrome P-450 during oxidative drug metabolism
14. The role of the cytochromes P450 in the detoxication and activation of drugs and other chemicals
15. Inhibition and induction of human cytochrome P450 (CYP) enzymes
16. p-Nitrophenol hydroxylation: A microsomal oxidation which is highly inducible by ethanol
17. Induction of hepatic microsomal CYP4A activity and of peroxisomal, -oxidation by two non-steroidal anti-inflammatory drugs
18. In vivo interaction of spironolactone and phenobarbital with cholesterol; effect on cholesterol organ concentration
19. Relationship between lipid composition and drug metabolizing capacity of human liver
20. Validation of 4-nitrophenol as an in vitro substrate probe for human liver CYP2E1 using cDNA expression and microsomal kinetic techniques
21. Xenobiotic Metabolism: The biochemical view
22. Identification of the cytochrome P-450 induced by macrolide antibiotics in the rat liver as the glucocorticoid responsive cytochrome P-450p